Delivery Order SPE2DB22D2009-SPE2DB25FL9HM
Award Date
5/20/25
Potential Completion Date
5/21/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $10,092.99. The contract has an ultimate completion date of May 27, 2025. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,469.78 firm fixed-price contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $11,020.86 and a period of performance through May 20, 2025. The award is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,157.95, is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of September 25, 2023. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,568.95 contract is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price, indefinite delivery vehicle with an ultimate completion date of April 14, 2025. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,723.33 firm fixed-price contract is for the delivery of REXULTI 2 MG TABLET 30S, with a period of performance through May 23, 2025. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania, and this contract is not designated as a set-aside. The company holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $56,834.34, is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of July 3, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,303.57 firm-fixed-price contract is for the supply of REXULTI 3 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,887.69 firm fixed-price delivery order is for the supply of REXULTI 3 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of REXULTI 0.5 MG TABLET 30S. The $18,463.48 firm fixed-price contract has a completion date of May 23, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...